AU1651788A - Creación de Inventos y Patentes con Inteligencia Artificial

AU1651788A – Dispenser with movable matrix comprising a plurality of tiny pills
– Google Patents

AU1651788A – Dispenser with movable matrix comprising a plurality of tiny pills
– Google Patents
Dispenser with movable matrix comprising a plurality of tiny pills

Info

Publication number
AU1651788A

AU1651788A
AU16517/88A
AU1651788A
AU1651788A
AU 1651788 A
AU1651788 A
AU 1651788A
AU 16517/88 A
AU16517/88 A
AU 16517/88A
AU 1651788 A
AU1651788 A
AU 1651788A
AU 1651788 A
AU1651788 A
AU 1651788A
Authority
AU
Australia
Prior art keywords
dispenser
movable matrix
tiny pills
tiny
pills
Prior art date
1987-07-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Application number
AU16517/88A
Other versions

AU613040B2
(en

Inventor
Richard Cortese
James B. Eckenhoff
Felix Theeuwes
Patrick S.L. Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Alza Corp

Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-07-13
Filing date
1988-05-20
Publication date
1989-01-19

1988-05-20
Application filed by Alza Corp
filed
Critical
Alza Corp

1989-01-19
Publication of AU1651788A
publication
Critical
patent/AU1651788A/en

1991-07-25
Application granted
granted
Critical

1991-07-25
Publication of AU613040B2
publication
Critical
patent/AU613040B2/en

2008-05-20
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/0012—Galenical forms characterised by the site of application

A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

A61K9/0068—Rumen, e.g. rumen bolus

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy

A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

AU16517/88A
1987-07-13
1988-05-20
Dispenser with movable matrix comprising a plurality of tiny pills

Ceased

AU613040B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US07/072,506

US4824675A
(en)

1987-07-13
1987-07-13
Dispenser with movable matrix comprising a plurality of tiny pills

US072506

1987-07-13

Publications (2)

Publication Number
Publication Date

AU1651788A
true

AU1651788A
(en)

1989-01-19

AU613040B2

AU613040B2
(en)

1991-07-25

Family
ID=22108037
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU16517/88A
Ceased

AU613040B2
(en)

1987-07-13
1988-05-20
Dispenser with movable matrix comprising a plurality of tiny pills

Country Status (7)

Country
Link

US
(1)

US4824675A
(en)

EP
(1)

EP0300623B1
(en)

JP
(1)

JPS6431710A
(en)

AU
(1)

AU613040B2
(en)

CA
(1)

CA1319071C
(en)

DE
(1)

DE3871273D1
(en)

ES
(1)

ES2031238T3
(en)

Families Citing this family (70)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4892778A
(en)

1987-05-27
1990-01-09
Alza Corporation
Juxtaposed laminated arrangement

US4940465A
(en)

1987-05-27
1990-07-10
Felix Theeuwes
Dispenser comprising displaceable matrix with solid state properties

GB8730011D0
(en)

1987-12-23
1988-02-03
Smithkline Dauelsberg
Pharmaceutical compositions

JPH03504246A
(en)

1988-05-16
1991-09-19
アメリカ合衆国

Chemotherapeutic composition for AIDS

JPH0818971B2
(en)

1989-02-16
1996-02-28
ブリティッシュ・テクノロジー・グループ・リミテッド

Dosage formulation

US5019396A
(en)

1989-05-12
1991-05-28
Alza Corporation
Delivery dispenser for treating cardiac arrhythmias

US5273752A
(en)

1989-07-18
1993-12-28
Alza Corporation
Controlled release dispenser comprising beneficial agent

US5035897A
(en)

1989-09-05
1991-07-30
Alza Corporation
Dosage form for delivering soluble or insoluble drugs

US5013557A
(en)

1989-10-03
1991-05-07
Warner-Lambert Company
Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same

US5576306A
(en)

1991-03-01
1996-11-19
Dow Chemical Company
Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers

US5721221A
(en)

1991-03-08
1998-02-24
Regents Of The University Of Minnesota
Lowering blood cholesterol levels using water soluble cellulose ethers

US5240713A
(en)

1991-09-27
1993-08-31
Alza Corporation
Dual rate agent delivery device

US5462741A
(en)

1992-08-06
1995-10-31
Alza Corporation
High agent loaded controlled release dispenser

US5315190A
(en)

1992-12-22
1994-05-24
Stirling Technology Company
Linear electrodynamic machine and method of using same

US6440457B1
(en)

1993-05-27
2002-08-27
Alza Corporation
Method of administering antidepressant dosage form

US5399359A
(en)

1994-03-04
1995-03-21
Edward Mendell Co., Inc.
Controlled release oxybutynin formulations

IE940292A1
(en)

1994-04-06
1995-10-18
Elan Corp Plc
Biodegradable microcapsules and method for their manufacture

US5399362A
(en)

1994-04-25
1995-03-21
Edward Mendell Co., Inc.
Once-a-day metoprolol oral dosage form

US5629021A
(en)

1995-01-31
1997-05-13
Novavax, Inc.
Micellar nanoparticles

US5698210A
(en)

1995-03-17
1997-12-16
Lee County Mosquito Control District
Controlled delivery compositions and processes for treating organisms in a column of water or on land

US6124355A
(en)

1995-05-22
2000-09-26
Guittard; George V.
Oxybutynin therapy

US5912268A
(en)

1995-05-22
1999-06-15
Alza Corporation
Dosage form and method for treating incontinence

US6262115B1
(en)

1995-05-22
2001-07-17
Alza Coporation
Method for the management of incontinence

US5674895A
(en)

1995-05-22
1997-10-07
Alza Corporation
Dosage form comprising oxybutynin

WO1997026865A1
(en)

1996-01-29
1997-07-31
Edward Mendell Co., Inc.
Sustained release excipient

US8071128B2
(en)

1996-06-14
2011-12-06
Kyowa Hakko Kirin Co., Ltd.
Intrabuccally rapidly disintegrating tablet and a production method of the tablets

US20040062799A1
(en)

1997-09-29
2004-04-01
Ayer Atul D.
Therapeutic composition and delivery system for administering drug

CA2327685C
(en)

1998-04-03
2008-11-18
Bm Research A/S
Controlled release composition

ATE277594T1
(en)

1998-06-03
2004-10-15
Alza Corp

DEVICES FOR ACHIEVED PROLONGED MEDICATION THERAPY

AUPR610501A0
(en)

2001-07-04
2001-07-26
Smart Drug Systems Inc
Treatment of parasitic disease

EP1429744A1
(en)

2001-09-21
2004-06-23
Egalet A/S
Morphine polymer release system

EP2957281A1
(en)

2001-09-21
2015-12-23
Egalet Ltd.
Polymer release system

US9358214B2
(en)

2001-10-04
2016-06-07
Adare Pharmaceuticals, Inc.
Timed, sustained release systems for propranolol

US6663888B2
(en)

2001-12-14
2003-12-16
Eurand Pharmaceuticals Ltd.
Pulsatile release histamine H2 antagonist dosage form

US20050025824A1
(en)

2001-12-14
2005-02-03
Eurand Pharmaceuticals Ltd.
Pulsatile release histamine H2 antagonist dosage form

AU2003230805A1
(en)

2002-04-05
2003-10-27
Penwest Pharmaceuticals Co.
Sustained release metoprolol formulations

AR039744A1
(en)

2002-06-26
2005-03-09
Alza Corp

METHODS AND DOSAGE FORMS TO INCREASE THE SOLUBILITY OF PHARMACOS COMPOSITIONS FOR CONTROLLED ADMINISTRATION

US20050208132A1
(en)

2002-07-29
2005-09-22
Gayatri Sathyan
Methods and dosage forms for reducing side effects of benzisozazole derivatives

NZ537543A
(en)

2002-07-29
2007-08-31
Alza Corp
Formulations and high dose osmotic dosage forms for controlled delivery of topiramate

US20050232995A1
(en)

2002-07-29
2005-10-20
Yam Nyomi V
Methods and dosage forms for controlled delivery of paliperidone and risperidone

US8367111B2
(en)

2002-12-31
2013-02-05
Aptalis Pharmatech, Inc.
Extended release dosage forms of propranolol hydrochloride

US8298581B2
(en)

2003-03-26
2012-10-30
Egalet A/S
Matrix compositions for controlled delivery of drug substances

EP2301526B1
(en)

2003-03-26
2016-03-23
Egalet Ltd.
Morphine controlled release system

CA2534920A1
(en)

2003-08-06
2005-02-24
Alza Corporation
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation

WO2005020957A2
(en)

2003-08-22
2005-03-10
Alza Corporation
Stepwise delivery of topiramate over prolonged period of time

EP1701697A2
(en)

2003-09-02
2006-09-20
ALZA Corporation
Novel drug compositions and dosage forms of topiramate

US20050169992A1
(en)

2003-12-23
2005-08-04
Frank Jao
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery

US20050175696A1
(en)

2003-12-29
2005-08-11
David Edgren
Drug granule coatings that impart smear resistance during mechanical compression

CA2550699A1
(en)

2003-12-29
2005-07-21
Alza Corporation, Inc.
Novel drug compositions and dosage forms of topiramate

WO2005065646A2
(en)

2003-12-29
2005-07-21
Alza Corporation, Inc.,
Novel drug compositions and dosage forms

US7713539B2
(en)

2004-07-19
2010-05-11
Boston Scientific Scimed, Inc.
Medical devices containing radiation resistant block copolymer

US8747895B2
(en)

2004-09-13
2014-06-10
Aptalis Pharmatech, Inc.
Orally disintegrating tablets of atomoxetine

US9884014B2
(en)

2004-10-12
2018-02-06
Adare Pharmaceuticals, Inc.
Taste-masked pharmaceutical compositions

AU2005299490C1
(en)

2004-10-21
2012-01-19
Adare Pharmaceuticals, Inc.
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers

US20060105038A1
(en)

2004-11-12
2006-05-18
Eurand Pharmaceuticals Limited
Taste-masked pharmaceutical compositions prepared by coacervation

US9161918B2
(en)

2005-05-02
2015-10-20
Adare Pharmaceuticals, Inc.
Timed, pulsatile release systems

WO2006128471A2
(en)

2005-06-03
2006-12-07
Egalet A/S
A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids

US8778395B2
(en)

2005-08-11
2014-07-15
Andrx Labs, Llc
Diltiazem controlled release formulation and method of manufacture

US7538652B2
(en)

2006-08-29
2009-05-26
International Business Machines Corporation
Electrical component tuned by conductive layer deletion

AU2008207200B2
(en)

2007-01-16
2011-02-17
Egalet Ltd
Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse

AU2008258596B2
(en)

2007-06-04
2013-02-14
Egalet Ltd
Controlled release pharmaceutical compositions for prolonged effect

NZ594207A
(en)

2009-02-06
2013-03-28
Egalet Ltd
Immediate release composition resistant to abuse by intake of alcohol

CA2766179A1
(en)

2009-06-24
2010-12-29
Egalet Ltd.
Controlled release formulations

TWI471146B
(en)

2009-12-02
2015-02-01
Aptalis Pharma Ltd
Fexofenadine microcapsules and compositions containing them

US9400873B2
(en)

2011-12-21
2016-07-26
Deka Products Limited Partnership
System, method, and apparatus for dispensing oral medications

US11065206B2
(en)

2011-06-29
2021-07-20
Avidas Pharmaceuticals, LLC
Topical formulations including lipid microcapsule delivery vehicles and their uses

JP2015521988A
(en)

2012-07-06
2015-08-03
イガレット・リミテッド

Abuse-preventing pharmaceutical composition for controlled release

CN104274411B
(en)

2014-10-28
2017-01-11
郑州合润生物制药有限公司
Tilmicosin micron preparation and preparation method thereof

US20200030242A1
(en)

2016-02-05
2020-01-30
Entrega Inc.
Oral dosage form with drying agent for delivery of active agent

EP3796958A4
(en)

2018-05-04
2022-01-26
Advanced Medical Solutions Israel (Sealantis) Ltd
Reconstitution and mixing systems

Family Cites Families (17)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US3995632A
(en)

1973-05-04
1976-12-07
Alza Corporation
Osmotic dispenser

US3946734A
(en)

1975-02-19
1976-03-30
The United States Of America As Represented By The Secretary Of State
Apparatus for controlling the release of a drug

AU520409B2
(en)

1977-05-25
1982-01-28
Commonwealth Scientific And Industrial Research Organisation
Controlled release composition

US4350271A
(en)

1980-08-22
1982-09-21
Alza Corporation
Water absorbing fluid dispenser

US4327725A
(en)

1980-11-25
1982-05-04
Alza Corporation
Osmotic device with hydrogel driving member

US4434153A
(en)

1982-03-22
1984-02-28
Alza Corporation
Drug delivery system comprising a reservoir containing a plurality of tiny pills

US4659558A
(en)

1982-03-22
1987-04-21
Alza Corporation
Oral delivery system comprising a plurality of tiny pills for delivering drug in the stomach and intestine

US4764380A
(en)

1982-03-22
1988-08-16
Alza Corporation
Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills

US4612008A
(en)

1983-05-11
1986-09-16
Alza Corporation
Osmotic device with dual thermodynamic activity

US4595583A
(en)

1984-03-19
1986-06-17
Alza Corporation
Delivery system controlled administration of beneficial agent to ruminants

US4717566A
(en)

1984-03-19
1988-01-05
Alza Corporation
Dosage system and method of using same

US4772474A
(en)

1985-08-09
1988-09-20
Alza Corporation
Dispenser with internal arrangement of lamina means for dispensing beneficial agent

GB2155889B
(en)

1984-03-21
1988-03-02
Alza Corp
Dispenser-capsule

US4609374A
(en)

1985-04-22
1986-09-02
Alza Corporation
Osmotic device comprising means for governing initial time of agent release therefrom

US4717718A
(en)

1985-08-09
1988-01-05
Alza Corporation
Device for the controlled delivery of a beneficial agent

US4675174A
(en)

1985-08-16
1987-06-23
Alza Corporation
Veterinary dispenser delivering beneficial agent by gas power generated in situ

CH668187A5
(en)

1986-08-07
1988-12-15
Ciba Geigy Ag

THERAPEUTIC SYSTEM WITH SYSTEMIC EFFECT.

1987

1987-07-13
US
US07/072,506
patent/US4824675A/en
not_active
Expired – Lifetime

1988

1988-05-20
AU
AU16517/88A
patent/AU613040B2/en
not_active
Ceased

1988-06-24
ES
ES198888305757T
patent/ES2031238T3/en
not_active
Expired – Lifetime

1988-06-24
DE
DE8888305757T
patent/DE3871273D1/en
not_active
Expired – Fee Related

1988-06-24
EP
EP88305757A
patent/EP0300623B1/en
not_active
Expired

1988-07-12
JP
JP63173643A
patent/JPS6431710A/en
active
Pending

1988-07-12
CA
CA000571765A
patent/CA1319071C/en
not_active
Expired – Fee Related

Also Published As

Publication number
Publication date

ES2031238T3
(en)

1992-12-01

EP0300623A3
(en)

1989-03-22

US4824675A
(en)

1989-04-25

JPS6431710A
(en)

1989-02-02

DE3871273D1
(en)

1992-06-25

EP0300623A2
(en)

1989-01-25

AU613040B2
(en)

1991-07-25

CA1319071C
(en)

1993-06-15

EP0300623B1
(en)

1992-05-20

Información de contacto